Literature DB >> 11669470

Effects of the opioid remifentanil on olfactory function in healthy volunteers.

J Lötsch1, J Darimont, C Skarke, M Zimmermann, T Hummel, G Geisslinger.   

Abstract

The effects of opioids on human subjective olfactory function have rarely been investigated. This is despite the fact that opioid receptors are widely distributed throughout the olfactory systems. Using an established validated test of subjective olfactory function, olfactory threshold, odor discrimination and odor identification performance were tested in 16 healthy volunteers before opioid administration and at steady state after 3 hours remifentanil infusion. Each one man and one women were assigned randomly to one out of eight predefined remifentanil target plasma concentrations: 0, 1.2, 1.8, 2.4, 3, 3.6, 4.8, and 6 ng/ml. In the thirteen subjects that had completed the tests, olfactory thresholds were elevated with increasing remifentanil dose, and this correlated statistically significant with the remifentanil dose. Remifentanil plasma concentrations were linearly related to changes in olfactory thresholds. In contrast, effects of remifentanil on odor discrimination and identification were not statistically significant. However, remifentanil target plasma concentrations were also significantly correlated with the subjects' ratings of tiredness and drowsiness, although only drowsiness was significantly correlated with the differences in odor thresholds. We conclude that opioid administration leads to impaired olfactory function expressed in raised olfactory thresholds. This is compatible with previously reported opioidergic effects at the level of the olfactory bulb.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11669470     DOI: 10.1016/s0024-3205(01)01305-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Drug-target based cross-sectional analysis of olfactory drug effects.

Authors:  Jörn Lötsch; Helena Daiker; Antje Hähner; Alfred Ultsch; Thomas Hummel
Journal:  Eur J Clin Pharmacol       Date:  2015-02-11       Impact factor: 2.953

Review 2.  Olfaction under metabolic influences.

Authors:  Brigitte Palouzier-Paulignan; Marie-Christine Lacroix; Pascaline Aimé; Christine Baly; Monique Caillol; Patrice Congar; A Karyn Julliard; Kristal Tucker; Debra Ann Fadool
Journal:  Chem Senses       Date:  2012-07-25       Impact factor: 3.160

3.  Necessity and risks of arterial blood sampling in healthy volunteer studies.

Authors:  Bruno Georg Oertel; Johannes Vermehren; Michael Zimmermann; Thomas Tao Huynh; Alexandra Doehring; Nerea Ferreiros; Stephan Senzel; Thomas Schmitz-Rixen; Matthias Erbe; Gerd Geisslinger; Sebastian Harder; Martin S Angst; Jörn Lötsch
Journal:  Clin Pharmacokinet       Date:  2012-10-01       Impact factor: 6.447

4.  Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjects.

Authors:  Lisa Felden; Carmen Walter; Carlo Angioni; Yannick Schreiber; Nils von Hentig; Nerea Ferreiros; Gerd Geisslinger; Jörn Lötsch
Journal:  Pharm Res       Date:  2014-01-28       Impact factor: 4.200

5.  Non-invasive combined surrogates of remifentanil blood concentrations with relevance to analgesia.

Authors:  Jörn Lötsch; Carsten Skarke; Jutta Darimont; Michael Zimmermann; Lutz Bräutigam; Gerd Geisslinger; Alfred Ultsch; Bruno G Oertel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-18       Impact factor: 3.000

6.  Overrated hedonic judgment of odors in patients with schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Janusz Śmigielski; Magdalena Kotlicka-Antczak
Journal:  CNS Neurosci Ther       Date:  2018-04-11       Impact factor: 5.243

7.  Machine-learned pattern identification in olfactory subtest results.

Authors:  Jörn Lötsch; Thomas Hummel; Alfred Ultsch
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

8.  Odor perception and hedonics in chronic schizophrenia and in first episode psychosis.

Authors:  Małgorzata Urban-Kowalczyk; Dominik Strzelecki; Janusz Śmigielski; Magdalena Kotlicka-Antczak
Journal:  Neuropsychiatr Dis Treat       Date:  2019-03-05       Impact factor: 2.570

Review 9.  Could Early Identification of Changes in Olfactory Function Be an Indicator of Preclinical Neurodegenerative Disease? A Systematic Review.

Authors:  Rikki L Winchester; Kathy Martyn
Journal:  Neurol Ther       Date:  2020-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.